SUVEN2024-01-012024-03-31 SUVEN2024-01-012024-03-31 SUVEN2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member SUVEN2024-01-012024-03-31in-bse-fin:OneOperatingExpenses02Member SUVEN2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member SUVEN2024-01-012024-03-31in-bse-fin:FourOperatingExpenses02Member SUVEN2024-03-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 530239 SUVEN NOTLISTED Suven Life Sciences Limited Equity 2023-04-01 2024-03-31 2024-05-06 2024-04-29 INR Lakhs Yearly 17:30:00 18:30:00 2024-05-06 2024-05-06 true Cash Flow Indirect Declaration of unmodified opinion Single segment The Company has only one business segment, i.e. Research & Development and does not operate in any other segments. Hence, segment reporting as per IND AS 108 (Operating Segment) is not presented 2024-01-01 2024-03-31 Unaudited Standalone 23852000.00 42831000.00 66683000.00 0.00 0.00 0.00 34635000.00 299000.00 15104000.00 57908000.00 107946000.00 -41263000.00 0.00 -41263000.00 -10024000.00 0.00 -10024000.00 0.00 -31239000.00 0.00 0.00 0.00 0.00 -31239000.00 -2024000.00 -33263000.00 0.00 0.00 218074000.00 1 -0.14 -0.14 0.00 0.00 -0.14 -0.14 1) The above financial results of the Company has been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 06, 2024. The results for the year ended March 31, 2024 has been audited and for the quarter ended March 31, 2024 has been reviewed by our statutory auditors. 2) The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder. 3) The consolidated financial results include the results of the wholly Owned Subsidiary, Suven Neurosciences, Inc. 4) The Company has only one business segment, i.e. Research & Development and does not operate in any other segments. Hence, segment reporting as per IND AS 108 (Operating Segment) is not presented. 5) The Company has alloted 72691239 equity shares amounting to Rs.399.80 Crores through rights issue on November 16, 2022. Summary of Utilisation of Proceeds of Rights issue Particulars Amount Rs.In lakhs Amout Raised through Rights Issue of Shares 39980.18 Less: Rights Issue Expenses -280 Less: Amount Utilised -25521.94 Balance Amount 14178.24 6) Pursuant to a fire accident on April 26, 2020 at Jeedimetla Plant, certain fixed assets and other materials in the affected buildings were damaged. The insurance claim was settled and the Company has received total payment from the Insurnace Company of Rs.19.45 Crores (including the final payment of Rs.7.45 Crores received during the second quarter of FY2023-24). 7) The figures for the current quarter and quarter ended March 31, 2023 are the balancing figures between the audited figures inrespect of full financial year ended March 31, 2024 and March 31, 2023, respectively and published year to date figures upto 3rd quarter ended 31st December 2023 and 31st December 2022, respectively, regrouped as necessary. Single segment 2023-04-01 2024-03-31 Audited Standalone 116929000.00 211300000.00 328229000.00 0.00 0.00 0.00 165337000.00 1584000.00 65022000.00 260959000.00 492902000.00 -164673000.00 74566000.00 -90107000.00 -10024000.00 0.00 -10024000.00 0.00 -80083000.00 0.00 0.00 0.00 0.00 -80083000.00 -600000.00 -80683000.00 0.00 0.00 218074000.00 1 8235688000.00 -0.37 -0.37 0.00 0.00 -0.37 -0.37 Other Expenses 16149000.00 R & D Expenses 41759000.00 Other Expenses 57072000.00 R & D Expenses 203887000.00 274951000.00 0.00 0.00 0.00 1986000.00 0.00 0.00 0.00 5771134000.00 0.00 0.00 150000.00 5771284000.00 0.00 5205000.00 6053426000.00 7085000.00 759351000.00 12860000.00 43997000.00 1490471000.00 0.00 22018000.00 2328697000.00 17951000.00 107675000.00 2461408000.00 0.00 0.00 8514834000.00 218074000.00 8235688000.00 8453762000.00 8453762000.00 0.00 0.00 0.00 0.00 13460000.00 0.00 0.00 0.00 13460000.00 0.00 20681000.00 10680000.00 31361000.00 5084000.00 11167000.00 0.00 0.00 47612000.00 0.00 0.00 61072000.00 8514834000.00 1584000.00 -7084000.00 -4786000.00 0.00 51121000.00 8577000.00 0.00 0.00 0.00 4032000.00 0.00 514000.00 0.00 58160000.00 0.00 292000.00 -5364000.00 -29000.00 0.00 0.00 0.00 -164252000.00 0.00 -45491000.00 0.00 0.00 -74566000.00 0.00 0.00 151212000.00 61105000.00 0.00 0.00 0.00 -61769000.00 0.00 122874000.00 0.00 952572000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -24212000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -164252000.00 0.00 757323000.00 0.00 -335289000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8956000.00 0.00 1584000.00 0.00 0.00 -10540000.00 -222955000.00 0.00 -222955000.00 266952000.00 43997000.00 2024000.00 600000.00 0.00 0.00